Amrutanjan Health Care Ltd-$ - 590006 - Board Meeting Outcome for Outcome Of Board Meeting
Amrutanjan Board approved its FY26 financial results, reporting revenue of ₹502.55 cr and net profit of ₹57.92 cr, representing YoY growth of 11.2% and 13.9%, respectively. The board also recommended a final dividend of ₹2.90 per equity share and approved the appointment and re-appointment of independent directors.
May 08 2026 16:05:00
Amrutanjan Health Care Ltd-$ - 590006 - Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For The Quarter And Year Ended 31 March 2026 Recommendation Of Final Dividend For The Year 2025-26
Amrutanjan Health Care board will meet on May 8, 2026, through video conferencing to consider and approve its audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for the financial year 2025-26.
Apr 30 2026 17:04:00
Amrutanjan Health Care Limited
Amrutanjan Health Care Limited's Board of Directors will meet on May 8, 2026, to consider and approve the company's annual standalone audited financial results for the financial year ended March 31, 2026, and a final dividend.
Apr 30 2026 17:04:00
Amrutanjan Health Care Ltd-$ - 590006 - Product Launch
Amrutanjan Health Care launched new product ranges including razors, medicated plasters, and Ortho Pain Relief + Oil on April 17, 2026. This move diversifies its portfolio and strengthens its presence in the domestic personal and healthcare markets.
Apr 17 2026 15:04:00
Amrutanjan Health Care Limited
Amrutanjan Health Care has launched a new range of Personal Care, Wound Care, and Pain Management products, marking a strategic entry into fast-growing grooming segments. The new offerings include women's and men's razors, medicated antiseptic plasters, and clinically proven Ortho Pain Relief Oil.
Apr 17 2026 15:04:00
Read More